NanoGroup S.A. (WSE:NNG)
Poland
· Delayed Price · Currency is PLN 3.050
-0.070 (-2.24%)
Apr 3, 2025, 1:39 PM CET
NanoGroup Revenue
In the year 2024, NanoGroup had annual revenue of 2.10K PLN with 4.01% growth. NanoGroup had revenue of -6.90K in the quarter ending December 31, 2024, a decrease of -1.16%.
Revenue
2.10K
Revenue Growth
+4.01%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
98.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | 687.51K | 169.78K | 32.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Oct 29, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 492.41M |
| Celon Pharma | 209.54M |
| Selvita | 345.76M |
| Ryvu Therapeutics | 101.96M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Scope Fluidics | 119.00K |